Kev Dhaliwal is Professor of Molecular Imaging and Healthcare Technology at the University of Edinburgh and a Consultant Physician in Respiratory Medicine. He was appointed Interim Director for Edinburgh Futures Institute in November 2023.
Kev trained as a medical student in the Old Royal Infirmary and his first job as a doctor looking after patients was on the Surgical Corridor, which is now the Futures Institute. He graduated from the University of Edinburgh and completed general professional training in London before returning to Edinburgh to undertake a period of consolidated laboratory research. During his PhD he developed strategic partnerships across disciplines to take ideas and concepts into human trials and also to work with industry and commercialise his research. He works across multiple disciplines with an ethos of ‘team science’ and values of friendship, trust and integrity. His research and innovation activities focus on developing new technologies spanning the 4Ds in health research, data, diagnostics, devices and drugs. Collaborating widely with industry, he is an advocate of the need to work across scientific disciplines to translate research into compassionate, people-centred healthcare. He also works closely with partners in India.
His clinical practice is in the New Royal Infirmary of Edinburgh, and the newly established Healthcare Technology Accelerator Facility whose aim is to expedite the clinical and commercial translation of healthcare technologies spanning all specialities. He leads the Translational Healthcare Technologies Group at the University of Edinburgh which brings together basic and translational teams to drive new futuristic approaches for human disease. Kev’s group investigates disruptive technologies to advance respiratory medicine and critical care.
Both within his roles in the University and also outside the University, he is very involved in entrepreneurship and developing cross sector and cross institutional relationships. He is a board director of Codebase.
